Activation of Raphe Efferents to the Medial Prefrontal Cortex by Corticotropin-Releasing Factor: Correlation with Anxiety-Like Behavior

This publication has 70 references indexed in Scilit:

• The Role of Corticotropin‐Releasing Factor in the Pathophysiology of Affective and Anxiety Disorders: Laboratory and Clinical Studies
  Published by Wiley ,2007
• Inactivation of the ventromedial prefrontal cortex reduces expression of conditioned fear and impairs subsequent recall of extinction
  European Journal of Neuroscience, 2006
• Microinjection of urocortin 2 into the dorsal raphe nucleus activates serotonergic neurons and increases extracellular serotonin in the basolateral amygdala
  Neuroscience, 2004
• Ultrastructural evidence for a role of γ‐aminobutyric acid in mediating the effects of corticotropin‐releasing factor on the rat dorsal raphe serotonin system
  Journal of Comparative Neurology, 2004
• In Vivo Excitation of GABA Interneurons in the Medial Prefrontal Cortex through 5-HT3 Receptors
  Cerebral Cortex, 2004
• Increased corticotropin-releasing hormone immunoreactivity in monoamine-containing pontine nuclei of depressed suicide men
  Molecular Psychiatry, 2003
• Role of CRF 1 and CRF 2 receptors in fear and anxiety
  Neuroscience & Biobehavioral Reviews, 2001
• Effects of Corticotropin-Releasing Factor on Neuronal Activity in the Serotonergic Dorsal Raphe Nucleus
  Neuropsychopharmacology, 2000
• Invited review c-Fos as a transcription factor: a stressful (re)view from a functional map
  Neurochemistry International, 1998
• Action of serotonin in the medial prefrontal cortex: Mediation by serotonin₃‐like receptors
  Synapse, 1992